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A B S T R A C T
In this work, the phenolic composition of E. umbellata leaves and berries is reported. Berries were rich in fla-
vonols, whereas leaves presented abundant flavonols and ellagitannins. Then, the enzyme-inhibitory properties,
anti-glycation and antioxidant activities of E. umbellata and Sambucus lanceolata (its phenolic profile has been
already established in a previous work) were tested by several in vitro assays and compared. The simulated
gastrointestinal digestion resulted in a decrease on their phenolic composition. Nevertheless, both species still
had the ability to inhibit aldose reductase activity and protein glycation and scavenge free radicals at the end of
the process. Thus, the potential beneficial effects of E. umbellata and S. lanceolata seems to be kept to some extent
after passage throughout the digestive system. Altogether, this study provides further insight into investigation
of these species as dietary sources of bioactive compounds to lower the risk of type-2 diabetes and obesity.
1. Introduction
The incidence of diabetes mellitus (DM) is epidemically increasing
all over the world and is estimated to reach almost 600 million people
by the year of 2035 (Grewal, Bhardwaj, Pandita, Lather, & Sekhon,
2016; Nazir et al., 2018). The lack of physical activity and excessive
intake of carbohydrate and/or fat-rich foods has contributed to the
prevalence of type-2 diabetes (T2DM) (90–95% of all DM cases) (Ho
et al., 2017; Podsędek, Majewska, Redzynia, Sosnowska, &
Koziołkiewicz, 2014; Worsztynowicz, Napierała, Białas, Grajek, &
Olkowicz, 2014). The main signs of this metabolic condition is hy-
perglycaemia (raised blood sugar levels), which is due to deficiency or
abnormalities in insulin secretion and/or the insensitivity of target
tissues to the metabolic action of this hormone (Ho, Kase, Wangensteen,
& Barsett, 2017; You, Chen, Wang, Luo, & Jiang, 2011). If remained
untreated, chronic hyperglycaemia can lead to several complications,
affecting the cardiovascular, renal, neurological and visual systems
(Nazir et al., 2018; Yeh, Hsia, Lee, & Wu, 2017).
Among fruits, berries (or berry fruits) have been recently recognized
as “superfoods” due to their unique and appreciable phenolic contents
and associated health benefits (antioxidant, anti-inflammatory, anti-
diabetic, etc) (Edirisinghe & Burton-Freeman, 2016; Harris et al., 2014;
Ho, Nguyen, et al., 2017; McDougall & Stewart, 2005). Their anti-dia-
betic effects include regulation of glucose digestion and absorption,
reduction of oxidative stress and inflammation, inhibition of the polyol
pathway, prevention of protein glycation, etc. (Edirisinghe & Burton-
Freeman, 2016; Harris et al., 2014; Nazir et al., 2018). Hence, berries
consumption can constitute an easy, safe and cost-effective dietary
approach to suppress hyperglycaemia and its associated complications
(Edirisinghe & Burton-Freeman, 2016; McDougall, Kulkarni, & Stewart,
2008; McDougall & Stewart, 2005). Infusions and decoctions of leaves
from berry-producing plants are also prepared due to their medicinal
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value (Ferlemi & Lamari, 2016). Generally, they possess higher and
richer phenolic composition than berries (Kim, Lim, & Yang, 2016;
Ozen, Yenigun, Altun, & Demirtas, 2017; Spínola, Pinto, & Castilho,
2018; Spínola, Pinto, Llorent-Martínez, Tomás, & Castilho, 2019), being
considered as alternative sources for the development of food supple-
ments and nutraceuticals (Ferlemi & Lamari, 2016).
To achieve any beneficial health effects, phenolic compounds must
be released from the berries along the gastrointestinal tract, remain in a
bioactive form, be absorbed from the gut into the bloodstream, and
then be delivered to the appropriate location within the body
(Bermúdez-Soto, Tomás-Barberán, & García-Conesa, 2007; Liang et al.,
2012; Tagliazucchi, Verzelloni, Bertolini, & Conte, 2010). Due to the
low-cost, simplicity, rapidity and reproducibility, in vitro digestion
models have been largely used as a first approach to simulate the
physiological conditions occurring in human digestion (Correa-Betanzo
et al., 2014; Guerra et al., 2012; Liang et al., 2012). The obtained results
provide a useful knowledge about the possible effects of pH and di-
gestive enzymes, food matrix and interactions with other components
in the stability and bioavailability of phenolic compounds during gas-
trointestinal digestion (Bermúdez-Soto et al., 2007).
Elaeagnus umbellata Thunb (Elaeagnaceae), commonly known as
Autumn olive or Japanese silverberry, is an indigenous species to
Central Asia (China, India, Afghanistan, Korea, Pakistan) (Nazir et al.,
2018; Ozen et al., 2017) that was introduced to Madeira Island (Por-
tugal). It is described as a deciduous shrub or small tree (typically up to
3.5 to 5.5. m tall) that grows a small, tasty fleshy drupe, which ripens to
red, dotted with silver or brown colour (Ishaq, Rathore, Sabir, &
Maroof, 2015; Khattak, 2012). Berries are very common in most Asian
countries diet, being also used to produce beverages, sauces, jams, etc.
(Ozen et al., 2017; Pei, Yu, Bruno, & Bolling, 2015). Sambucus lanceolata
R. Br. in Buch (Adoxaceae) (Madeira elderberry) or “sabugueiro” is a
small tree or shrub, up to 7m tall, endemic to Madeira Island (Por-
tugal). Berries are small yellowish round edible fruits that get dark-
purple when ripe in the late Summer (Pinto et al., 2017).
In view of the reported anti-diabetic benefits of berries and leaves
(Edirisinghe & Burton-Freeman, 2016; Ferlemi & Lamari, 2016), the
aim of this research was to evaluate the in vitro inhibitory activities of
both species on α-glucosidase, α-amylase, pancreatic lipase and aldose
reductase enzymes, as well as their anti-glycation and antioxidant ac-
tivities. The impact of simulated gastrointestinal digestion on the sta-
bility of phenolic compounds and changes on their potential bioactiv-
ities was also investigated.
2. Materials and methods
2.1. Chemicals and reagents
All reagents met the quality norms required for analytical grade
reagents. Acarbose, aminoguanidine hydrochloride (AMG), ammonium
sulfate, bovine serum albumin (BSA), α-amylase from porcine pancreas
(type VI-B), intestinal acetone powder from rat source of α-glucosidase,
lipase (type II; from porcine pancreas), DL-glyceraldehyde, β-mercap-
toethanol, mucin (type II; from porcine stomach), β-nicotinamide ade-
nine dinucleotide reduced (NADH), N-(1-Naphthyl)ethylenediamine
dihydrochloride, phenazine methosulfate, pancreatin (porcine pan-
creas), pepsin (porcine gastric mucosa), porcine bile extract, p-ni-
trophenyl-α-D-glucopyranoside, p-nitrophenyl butyrate, and orlistat
were all acquired from Sigma-Aldrich (St. Louis, MO, USA). Human
aldose reductase was purchased from Prozomix (Northumberland, UK)
and β-nicotinamide adenine dinucleotide reduced tetrasodium salt hy-
drate from Calbiochem (MA, USA). 1-Deoxynojirimycin (1-DNJ) was
acquired from Biopurify phytochemicals LTD (Chengdu, China).
Nitroblue tetrazolium chloride was purchased from Acros Organics
(Geel, Belgium). Other chemicals and reagents used in this study are
detailed in the Supplementary Material.
2.2. Sample preparation and extraction of phenolic compounds
Plant material (leaves and berries) of E. umbellata and S. lanceolata
were collected in different areas of Madeira Island (Portugal) in October
2014 and specimens were stored at Madeira Botanical Garden
Herbarium (Funchal, Madeira Island) (Table S1 – Supplementary
Material).
For analysis, samples were separated into leaves and fruits (fully
ripe), destemmed, washed, lyophilized (Alpha 1–2 LD plus freeze dryer,
CHRIST), ground to powder using a mechanic grinder, and stored at
−20 °C. Extraction of phenolic compounds followed a previous proce-
dure (Pinto et al., 2017). In brief, 1 g of dry material was extracted with
methanol in an ultra-sonic bath (Bandelin Sonorex, Germany) at 35 Hz
and 200W for 60min. For berry fruits, an extraction solution composed
of MeOH/H2O (80:20, v/v) acidulated with 7% acetic acid was used.
After sonication, solutions were filtered through Whatman No.1 filter
papers, concentrated to dryness in a rotary evaporator (at 40 °C), and
the resulting dry extracts (DE) were stored at 4 °C until further analysis.
2.3. Simulation of gastrointestinal digestion
The same static model previously reported (Pinto et al., 2017) was
used to simulate, sequentially, mouth, stomach and small intestine di-
gestion. For this, artificial gastrointestinal juices (saliva, gastric, duo-
denal, bile) were prepared freshly (Table S2-Supplementary Material).
In 50mL Falcon tubes, 2 g of lyophilized berries or leaves were mixed,
separately, with 4mL of salivary juice and immersed in a water bath
(37 °C) with agitation (150 rpm), protected from light (for 5min). Then,
10mL of gastric juice was added to the mixture and further incubated
for an additional 2 h. After this period, 10mL of duodenal and 4mL of
bile juices were added and the solution was mixed for 2 h. Two in-
dependent replicated digestions were performed for each sample. At the
end of the digestion simulation, samples were centrifuged (4000 rpm,
10min). Then, the supernatant was recovered and filtered through
Whatman No.1 filter papers, lyophilized and submitted to extraction (as
described in the previous section). The liquid extracts were con-
centrated to dryness and stored at 4 °C pending its use.
2.4. Analysis of phenolic compounds
The chromatographic analysis was carried out on a Dionex ultimate
3000 series instrument (Thermo Scientific Inc.) equipped with a binary
pump, an autosampler, a column compartment (kept at 30 °C) and a
diode-array detector (DAD) coupled to a Bruker Esquire model 6000
ion-trap mass spectrometer (Bremen, Germany). Separation was per-
formed on a Phenomenex Gemini C18 column (5 μm, 250×3.0mm
i.d.) using the same conditions reported previously (Pinto et al., 2017).
Water/formic acid (0.1%, v/v) (A) and CH3CN (B) was used as mobile
phase at a flow rate of 0.4 mLmin−1. The gradient program was set as:
20% A (0min), 25% A (10min), 25% A (20min), 50% A (40min),
100% A (42–47min) and 20% A (49–55min). Mass spectrometry
analysis was performed in negative and positive mode and scan range
was set at m/z 100–1000 with speed of 13,000 Da/s. The conditions of
ESI were as follows: drying and nebulizer gas (N2) flow rate and pres-
sure, 10 mLmin−1 and 50 psi; capillary temperature, 325 °C; capillary
voltage, 4.5 keV; collision gas (He) MSn data was made in auto MSn
mode, with isolation width of pressure and energy, 1×10−5mbar and
40 eV. The acquisition of 4.0 m/z, and a fragmentation amplitude of
1.0 V (MSn up to MS4).
2.5. Quantification of main polyphenols
For the determination of polyphenols in the analysed extracts, caf-
feic acid, quercetin, apigenin, (+)-catechin, and ellagic acid standards
were used for the relative quantification of hydroxycinnamic acids
(HCAs), flavonols, flavones, flavan-3-ols and ellagitannins, respectively
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(Pinto et al., 2017). The calibration curves (5–100mg L−1), obtained
plotting peak area versus concentration, had R2≥ 0.990 in all cases.
Total individual phenolic content (TIPC) was defined as the sum of the
relative concentrations of phenolic compounds in extracts.
2.6. Enzyme inhibition and protein glycation assays
α-Glucosidase, α-amylase, lipase, aldose reductase and BSA-glyca-
tion inhibition assays were determined using the procedures detailed in
the Supplementary Material. The obtained inhibitory activities were
expressed as the IC50 value (mgmL−1 of dry extract, DE).
2.7. In vitro antioxidant assays
The antioxidant activity of analysed extracts was determined by
ABTS•+, DPPH•, nitric oxide (NO•) and superoxide (O2•-) in vitro assays,
following the same procedures detailed in the Supplementary Material.
The results were expressed as μmol of Trolox equivalent (TE) g−1 DE,
based on the Trolox calibration curve.
2.8. Statistical analysis
Statistical analysis was performed using SPSS Statistics software
v.20 (IBM SPSS Statistics for Windows, IBM Corp., USA). Data of all
analysis, in triplicate, are expressed as mean ± standard deviation. A
one-way analysis of variance (ANOVA) was performed to determine
whether there are any statistically significant differences among para-
meters experimentally determined, followed by Tukey's HSD post-hoc
test. A value of p < .05 was considered statistically significant.
3. Results and discussion
3.1. Phytochemical screening
In this work, the analysis of phytochemical composition in the ex-
tracts of E. umbellata (berries and leaves) was carried out by HPLC-ESI-
MSn using negative and positive ionization modes (the latter used for
confirmation purposes). Compounds were numbered by their order of
elution and this numeration was kept identical for both extracts. The
characterization of compounds (Table 1) was assigned based on the
comparison of the experimental mass spectra with data from literature
(listed in the Supplementary Material). The discussion of the char-
acterization of compounds is explained in detail in the Supplementary
Material. A total of 94 phytochemicals were tentatively identified, in-
cluding flavonoids, phenolic acids, ellagitannins, organic acids, terpe-
noids and saccharides. The base peak chromatograms (BPCs) of the
methanol extracts are shown in Fig. S1 (Supplementary Material).
The composition of S. lanceolata methanolic extracts (berries and
leaves) has been previously characterised by our work group (Pinto
et al., 2017). Seventy-seven phytochemicals were described, namely
phenolic compounds (flavonoids and phenolic acids) and other sub-
stances (organic acids, oligosaccharides, lignans, terpenoids and fatty
acids).
3.2. Phenolic composition determination
Thirty-six phenolic compounds were quantified by HPLC-DAD in E.
umbellata extracts (Table 2).
TIPC varied between 5.56 and 40.35mg g−1 DE, corresponding to
berries and leaves, respectively (Table 2). Flavonols (78.8%) were the
most abundant compounds in berries, followed by ellagitannins (9%),
flavones (7.8%), flavan-3-ols (2.7%) and HCAs (1.8%). A different
composition was verified in the case of leaves: ellagitannins
(56.8%) > flavonols (40.7%) > HCAs (5.2%) > flavan-3-ols (2.1%).
Kaempferol-O-(coumaroyl)hexoside (87) was the dominant com-
pound in berries (37.2%) (Table 2). Quercetin-O-pentoside (49) (8.4%),
kaempferol-O-(coumaroyl)hexoside (89) (6.6%) and kaempferol-O-
hexoside (73) (6.1%) were also relevant. Bis-hexahydroxydiphenoyl
(HHDP)-O-hexoside (17) (26.7%) was the main compound in leaves,
followed by galloyl-HHDP-O-hexoside (21) (15.5%), quercetin-O-
(pentosyl)hexoside (51) (12.5%) and isorhamnetin-O-(pentosyl)hexo-
side (9.30%). Qualitative and quantitative differences were observed in
the literature. It was determined that E. umbellata berries were com-
posed mainly by phenolic acids (HCAs and hydroxybenzoic acids)
(Ishaq et al., 2015; Ozen et al., 2017), while other authors reported
flavan-3-ols (catechin and its polymers) (Pei et al., 2015). Nazir and co-
workers (Nazir et al., 2018) stated chlorogenic acid, quercetin, and
epigallocatechin-gallate as major phenolic compounds of berries. Gallic
acid and kaempferol (Kim et al., 2016) and hesperidin, rutin, neohe-
speridin, and ellagic acid were dominant in the leaves extracts (Ozen
et al., 2017). Observed discrepancies could be related to different
edaphoclimatic conditions and/or post-harvest procedures (sample
preparation, solvents, extraction methodologies, etc.).
In comparison with E. umbellata, extracts of S. lanceolata showed
higher and lower TIPC contents for berries and leaves, respectively
(Fig. 1). S. lanceolata berries were composed mainly by anthocyanins
(88.6%), which were absent in E. umbellata (confirmed by the positive
ionization mode and UV-spectrum at 520 nm). HCAs (57.1%) and fla-
vonols (42.9%) were dominant in the leaves of S. lanceolata (Pinto
et al., 2017).
After simulated digestion, qualitative and quantitative differences
were found in E. umbellata in relation to native values (p < .05)
(Table 2). Berries components were more unstable than leaves ones
(reductions of 71.05% and 62.24% of TIPC, respectively). Flavonols and
flavones from berries suffered degradations of 67.28% and 59.30%,
respectively. Kaempferol-O-(coumaroyl)hexoside (87) and quercetin-O-
pentoside (49) contents were reduced by 52.70% and 60.00%, respec-
tively. In the case of leaves, HCAs content showed the highest loss
(90.20%), followed by ellagitannins (62.59%) and flavonols (43.63%).
Main compounds, bis-HHDP-O-glucose (17), quercetin-O-pentosyl
(hexoside) (51) and galloyl-HHDP-O-hexoside (21) showed decreases of
62.51%, 43.10% and 61.68%, respectively, upon simulated digestion.
Information regarding the stability of phenolic compounds in the gas-
trointestinal tract occurring in E. umbellata is lacking in the literature.
However, a similar trend was verified for other berry-producing species,
with losses of TIPC ranging from 23.% to 80.5% (Bermúdez-Soto et al.,
2007; Correa-Betanzo et al., 2014; Olejnik et al., 2016; Zhang et al.,
2016). A reduction of TIPC was also observed for berries and leaves of
S. lanceolata (81.8% and 61.5%, respectively) upon simulated digestion
(Pinto et al., 2017). Anthocyanins content was highly affected
(−87.2%) in berries; HCAs (35.8–54.9%) and flavonoids (56.3–70.6%)
contents were also decreased in the leaves.
The loss of phenolic content is mainly attributed to the chemical
conditions during intestinal digestion, since most phenolic compounds
are highly sensitive to the mild alkaline conditions and their structures
may undergo modifications (hydrolysis, conversion/breakdown, etc.)
(Bermúdez-Soto et al., 2007; Huang, Sun, Lou, Li, & Ye, 2014; Zhang
et al., 2016). Anthocyanins are generally considered to be the most
unstable compounds at neutral or slightly basic pH (Bermúdez-Soto
et al., 2007; Correa-Betanzo et al., 2014; Liang et al., 2012; Olejnik
et al., 2016) due to the formation of the colorless chalcone pseudo-base
resulting in the destruction of the anthocyanins chromophore (Liang
et al., 2012; Pinto et al., 2017; Tagliazucchi et al., 2010). The non-
anthocyanin phenolic compounds are more stable at the intestinal al-
kaline pH value (Liang et al., 2012; Tagliazucchi et al., 2010), which
has been reported to cause oxidation and racemization of molecules
(Bermúdez-Soto et al., 2007). Interactions between phenolic com-
pounds and other components, such as digestive enzymes, pancreatin
bile salts, or even with other food matrix components (proteins, lipids,
fibers) can also limit their bioavailability (Bermúdez-Soto et al., 2007;
Zhang et al., 2016).
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Table 1
Characterization of phytochemicals of E. umbellata methanolic extracts by HPLC-ESI−/MSn. A more detailed explanation about the identification of compounds is
presented in the Supplementary material.
N° tR (min) [M-H]− (m/
z)
HPLC-DAD-ESI/MSn
m/z (% base peak)
Assigned identity Berries Leaves
1 3.1 179 MS2 [179]: 161 (76.9), 149 (17.8), 143 (76.5), 131 (24.7), 119 (47.6), 113 (57.6).
101 (27.8). 89 (100)
Hexose ✓ ✓
2 3.2 473 MS2 [473]: 342 (17.3), 341 (100), 221 (12.9), 179 (46.0), 132 (26.5)
MS3 [473→341]: 323(27.9), 281 (11.0), 179 (100), 161 (32.8), 143 (11.4)





3 3.3 295 MS2 [295]: 235 (20.6), 205 (21.9); 179 (99.4). 161 (13.5), 133 (100); 115 (11.4)





MS2 [683]: 342 (14.4), 341 (100)
MS3 [683→341]: 179 (100), 161 (30.2), 143 (18.1), 119 (13.2), 113 (20.3), 101
(14.3)
MS4 [683→341→179]:161 (58.6), 143 (43.6), 131 (15.4), 119 (46.9), 113 (20.2),




MS2 [591]: 295 (100)
MS3 [591→295]: 235 (21.8), 205 (19.6), 179 (100); 161 (11.1), 143 (11.2), 133
(71.3), 119 (10.7), 113 (12.1), 89 (13.3)
Hexosyl-malic acid dimer ✓
6 3.5 533 MS2 [533]: 191 (100.0)
MS3 [533→191]: 153 (11.4), 127 (100.0), 111 (26.6), 93 (74.5), 85 (66.5)
Quinic acid derivative ✓
7 3.6 481 MS2 [481]: 301 (100), 275 (19.2)
MS3 [481→301]: 257 (38.3), 245 (23.8), 185 (100)
HHDP-O-glucose ✓
8 3.7 191 MS2 [191]: 173 (76.9), 171 (13.8), 127 (100.0), 111 (77.5), 109 (37.4), 93 (47.9), 87
(28.2), 85 (82.9), 81 (17.6)
MS3 [191→127]: 109 (21.1), 85 (100)
Quinic acid ✓
9 3.9 133 MS2 [133]: 115 (100)
MS3 [133→115]: 71 (100)
Malic acid ✓ ✓
10 4.0 783 MS2 [783]: 765 (10.8), 721 (10.4), 481 (41.7), 301 (100), 275 (23.7)
MS3 [783→301]: 299 (100), 257 (22.8), 256 (24.5), 240 (14.6), 230 (21.0), 157
(10.1)
bis-HHDP-O-glucose ✓
11 4.4 191 MS2 [191]: 173 (18.7), 111 (100)
MS3 [191→111]: 67 (100)
Citric acid ✓
12 4.6 481 MS2 [481]:301 (100), 275 (12.8)
MS3 [481→301]:257 (100), 242 (54.5), 229 (41.9), 214 (51.5), 186 (72.9), 173
(84.1), 147 (38.0)
HHDP-O-glucose ✓
13 4.9 783 MS2 [783]:765 (12.5), 721 (13.0), 481 (38.4), 301 (100), 275 (28.7)
MS3 [783→301]:299 (100), 284 (19.8), 257 (19.4), 245 (18.9), 229,811.7), 213
(77.9)
MS4 [783→301→299]: 281 (100)
bis-HHDP-O-glucose ✓
14 5.2 757 MS2 [757]: 596 (25.2), 595 (100)
MS3 [757→595]: 445 (17.9), 301 (49.8), 300 (100), 271 (14.9), 255 (11.0)
MS4 [757→595→301]: 273 (11.5), 272 (27.2), 271 (100), 256 (11.6), 255 (30.0),




15 5.4 783 MS2 [783]: 669 (11.6), 481 (11.3), 301 (100), 275 (18.5), 249 (22.4), 243 (12.6) bis-HHDP-O-glucose ✓
16 5.7 305 MS2 [305]: 261 (12.2), 221 (47,7), 219 (56.0), 179 (100), 165 (28.1), 137 (30.8), 125
(40.2)
MS3 [305→179]: 165 (66.9), 164 (53.2), 152 (35.0), 151 (100), 135 (76.1)
Gallo(epi)catechin ✓
17 5.8 783 MS2 [783]:481 (30.5), 301 (100), 275 (17.8)
MS3 [783→301]: 300 (10.5), 285 (15.7), 283 (24.3), 273 (14.8), 257 (87.8), 245
(34.6), 241 (23.9), 229 (100), 213 (29.7)
MS4 [783→301→257]:185 (100)
bis-HHDP-O-glucose ✓
18 6.1 583 MS2 [583]:538 (25.6), 537 (100)
MS3 [583→537]:491 (60.2), 406 (16.0), 405 (100), 293 (29.0), 243 (34.4), 225
(10.4), 191 (71.3), 168 (21.4), 161 (25.3), 149 (55.7)
Unknown ✓
19 6.5 451 MS2 [451]:405 (100)
MS3 [451→405]: 243 (46.7), 179 (25.7), 167 (20.5), 161 (12.7), 153 (44.0), 149
(100), 143 (11.6), 119 (22.2)
Saccharide ✓ ✓
20 7.0 783 MS2 [783]: 481 (27.0), 301 (100), 275 (16.3)
MS3 [783→301]: 273 (25.5), 258 (23.9), 257 (100), 229 (35.8), 227 (22.3),
213,815.4), 202 (22.8), 186 (38.4), 169 (30.4), 145 (27.1)
bis-HHDP-O-glucose ✓ ✓
21 7.4 633 MS2 [633]: 614 (17.1), 463 (13.2), 301 (100), 273 (10.7), 271 (13.9)
MS3 [633→301]: 299 (53.5), 257 (100)
Galloyl-HHDP-O-glucose ✓ ✓
22 7.9 633 MS2 [633]: 301 (100)
MS3 [633→301]: 286 (12.1), 275 (27.6), 258 (60.9), 257 (100), 245 (20.1), 230
(27.7), 229 (32.8), 202 (48.9), 201 (14.9), 186 (44.1)
Galloyl-HHDP-O-glucose ✓ ✓
23 8.0 551 MS2 [551]: 529 (100)
MS3 [551→529]: 467 (100), 458 (20.6), 301 (10.6)
MS4 [551→529→467]: 301 (100), 299 (53.0), 289 (14.3), 285 (50.0), 277 (43.5),
169 (84.6), 125 (38.1)
Gallic acid derivative ✓
24 8.3 935 MS2 [935]: 917 (20.9), 659 (21.2), 633 (100), 615 (36.7), 571 (18.5), 329 (25.4), 301
(21.9), 299 (49.4)
MS3 [935→633]: 615 (76.5), 571 (70.3), 481 (44.3), 383 (31.7), 329 (76.1), 301
(28.7), 299 (100), 275 (26.5)
Galloyl-bis-HHDP-glucose ✓
(continued on next page)
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Table 1 (continued)
N° tR (min) [M-H]− (m/
z)
HPLC-DAD-ESI/MSn
m/z (% base peak)
Assigned identity Berries Leaves
25 8.5 563 MS2 [563]: 517 (100)
MS3 [563→517]: 385 (93.1), 223 (89.7), 208 (100), 164 (52.3)




26 8.6 755 MS2 [755]: 610 (23.7), 609 (100)
MS3 [755→609]: 430 (11.9), 429 (57.4), 285 (100), 284 (55.4), 257 (17.2), 255
(15.2)




27 8.7 741 MS2 [741]: 595 (100), 446 (11.3), 271 (10.6)
MS3 [741→595]: 475 (33.1), 449 (22.3), 301 (44.4), 300 (100), 271 (15.5), 215
(11.0), 179 (11.1)




28 8.8 563 MS2 [563]: 518 (24.4), 517 (100)





29 9.0 385 MS2 [385]: 223 (100), 205 (73.6), 163 (10.5)
MS3 [385→223]: 208 (17.0), 164 (100), 149 (12.1)
Sinapic acid-O-hexoside ✓
30 9.1 741 MS2 [741]: 595 (100), 446 (12.0), 300 (17.0)
MS3 [741→595]: 463 (20.2), 445 (43.7), 368 (19.3), 343 (36.2), 301 (38.0), 300
(100), 273 (42.1), 257 (10.1), 179 (15.4)




31 9.3 565 MS2 [565]: 520 (13.0), 519 (17.8), 403 (100), 385 (14.7), 325 (10.9), 223 (66.9), 221
(15.4), 179 (16.6)
MS3 [565→403]: 223 (89.5), 149 (27.5), 135 (100)
Caffeic acid-O-(sinapoyl-O-hexoside) ✓ ✓
32 9.5 431 MS2 [431]: 385 (100), 223 (13.5)
MS3 [431→385]: 223 (64.4), 206 (11.7), 205 (48.9), 161 (21.2), 153 (100), 138
(18.5)
MS4 [431→385→153]: 138 (100), 136 (56.9), 114 (40.8), 97 (26.7)
Roseoside (formate adduct) ✓ ✓
33 9.8 759 MS2 [759]: 651 (16.0), 639 (30.8), 621 (20.3), 579 (53.8), 549 (100)
MS3 [759→549]: 531 (21.1), 519 (49.8), 491 (100), 477 (83.4), 315 (52.0), 271
(15.2)
MS4 [759→549→491]: 315 (100), 300 (76.9), 299 (40.8), 271 (36.7)
Isorhamnetin-O-glucuronide derivative ✓
34 10.5 489 MS2 [489]: 446 (10.6), 295 (15.0), 283 (11.9), 265 (18.5), 223 (100), 208 (11.6), 205
(45.3), 190 (30.4), 175 (20.7), 164 (34.1), 149 (37.5)
MS3 [489→223]: 208 (77.7), 179 (100), 164 (43.9)
Sinapic acid derivative ✓
35 10.6 385 MS2 [385]: 325 (100), 295 (92.3), 265 (84.6), 223 (25.8)
MS3 [385→325]: 307 (34.3), 265 (82.0), 223 (100), 206 (48.1)
MS4 [385→325→223]:164 (100)
Sinapic acid-O-hexoside ✓ ✓
36 10.7 725 MS2 [725]: 622 (12.8), 580(35.0), 579 (100)





37 10.9 449 MS2 [449]: 287 (100), 269 (32.4), 259 (53.9)
MS3 [449→287]: 259 (100), 243 (27.0), 201 (17.2), 173 (20.6), 151 (63.6), 125
(40.1), 119 (10.6)
Dihydrokaempferol-O-hexoside ✓
38 11.1 755 MS2 [755]: 609 (100)
MS3 [755→609]: 459 (25.7), 315 (100), 300 (13.4), 299 (13.6), 271 (16.9), 243
(13.3)




39 11.2 611 MS2 [611]: 474 (15.9), 463 (22.8), 447 (17.0), 329 (12.3), 317 (100), 272 (11.0),
270(20.0), 251 (18.4)
MS3 [611→317]: 272 (76.2), 271 (100), 179 (25.0)
Myricetin-O-(pentosyl)hexoside ✓
40 11.4 463 MS2 [463]: 301 (100), 300 (35.6)
MS3 [463→301]: 300 (90.9), 257 (100), 229 (61.3), 207 (27.7), 172 (33.3)
Ellagic acid-O-hexoside ✓
41 11.8 503 MS2 [503]: 223 (100), 205 (56.7), 191 (22.0), 164 (14.1), 149 (25.9)
MS3 [503→223]: 179 (100), 164 (65.5), 149 (76.1)
Sinapic acid derivative ✓
42 12.7 475 MS2 [475]: 301 (100), 275 (11.3)
MS3 [475→301]: 257 (100), 230 (22.3), 213 (27.5), 201 (29.8), 200 (29.0), 192
(34.7), 186 (14.7), 185 (34.0)
Ellagic acid-O-(acetyl)pentoside ✓
43 13.0 625 MS2 [625]: 505 (15.6), 463 (12.0), 445 (38.2), 301 (100), 300 (97.6), 271 (21.3), 255
(22.0)
MS3 [625→301]: 271 (100), 179 (50.6), 151 (41.5)
Quercetin-O-dihexoside ✓
44 13.2 371 MS2 [371]: 249 (100)
MS3 [371→249]: 231 (41.1), 113 (100), 99 (12.5), 95 (27.3), 85 (49.4)
Unknown ✓ ✓
45 13.9 371 MS2 [371]: 249 (100)
MS3 [371→249]: 231 (47.1), 175 (10.9), 113 (100), 111 (12.2), 99 (20.5), 85 (36.3)
Unknown ✓
46 14.0 389 MS2 [389]: 209 (100), 181 (19.1), 179 (76.2), 135 (35.8)
MS3 [389→209]: 135 (100)
Caffeic acid derivative ✓
47 14.3 725 MS2 [725]: 545 (100), 313 (12.9)
MS3 [725→545]: 351 (13.0), 313 (100), 295 (20.2), 249 (11.4), 247 (12.5), 231
(26.8), 229 (18.2), 187 (16.5), 179 (10.8), 161 (13.9)
MS4 [725→545→313]: 179 (100), 161 (85.9), 115 (40.7), 113 (63.4), 101 (63.4),
89 (49.0)
Saccharide ✓
48 14.4 595 MS2 [595]: 445 (14.8), 301 (46.2), 300 (100), 271 (20.6)
MS3 [595→301]: 271 (100), 257 (12.2), 255 (89.0), 243 (10.0), 179 (42.8), 151
(52.1)
Quercetin-O-(pentosyl)hexoside ✓ ✓
(continued on next page)
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Table 1 (continued)
N° tR (min) [M-H]− (m/
z)
HPLC-DAD-ESI/MSn
m/z (% base peak)
Assigned identity Berries Leaves
49 14.8 433 MS2 [433]: 301 (100), 300 (52.3
MS3 [433→301]: 300 (100), 257 (40.7), 179 (53.8), 151 (55.5)
Quercetin-O-pentoside ✓
50 15.1 609 MS2 [609]: 576 (57.3), 447 (72.2), 301 (48.2), 285 (100), 255 (25.1)
MS3 [609→285]: 255 (100)
Kaempferol-O-dihexoside ✓
51 15.1 595 MS2 [595]: 445 (10.9), 301 (57.6), 300 (100), 271 (15.4), 255 (11.9)
MS3 [595→300]: 271 (100), 255 (59.9), 179 (36.9), 151 (34.4)
Quercetin-O-pentosyl(hexoside) ✓
52 15.5 547 MS2 [547]:503 (10.6), 311 (100), 265 (10.9), 221 (13.6)
MS3 [547→311]: 293 (23.9), 275 (36.0), 251 (62.5), 233 (50.0), 221 (22.0), 179
(29.5), 161 (16.7), 149 (100), 113 (46.6)
Saccharide ✓
53 15.7 551 MS2 [551]: 505 (100)
MS3 [551→505]: 373 (100), 179 (22.3), 161 (54.4)
MS4 [551→505→373]: 161 (100), 119 (11.6), 113 (15.9)
Saccharide ✓
54 16.1 639 MS2 [639]: 477 (21.0), 315 (100), 300 (22.6), 299 (17.3), 271 (16.2)
MS3 [639→315]: 301 (11.0), 300 (100), 299 (22.6)
Isorhamnetin-O-dihexoside ✓
55 16.3 547 MS2 [547]: 311 (100), 191 (14.1), 161 (21.8)
MS3 [547→311]: 293 (15.1), 251 (22.0), 179 (42.4), 161 (78.9), 149 (100), 119
(10.3), 101 (85.1)
Saccharide ✓
56 16.6 597 MS2 [597]:489 (15.1), 477 (49.4), 459 (17.2), 417 (15.9), 387 (67.8), 357 (100)
MS3 [597→357]: 209 (100), 139 (11.0), 123 (27.6)
MS3 [597→387]: 315 (100), 239 (37.1), 221 (14.8), 191 (18.5), 167 (12.0), 161
(11.0), 153 (10.4)
MS4 [597→357→209]: 165 (28.3), 164 (63.7), 123 (100), 121 (23.6)
MS4 [597→357→315]: 209 (41.4), 190 (21.3), 167 (100), 139 (28.5) 126 (37.7)
Unknown ✓
57 17.1 551 MS2 [551]: 505 (100)
MS3 [551→505]: 373 (100), 161 (22.7)
MS4 [551→505→373]: 179 (17.9), 161 (100), 143 (18.3), 113 (25.9)
Saccharide ✓
58 17.4 547 MS2 [547]: 311 (100), 179 (14.1), 161 (21.8)
MS3 [547→311]: 293 (15.1), 251 (22.0), 179 (42.4), 161 (78.9), 149 (100), 119
(10.3), 101 (85.1)
Saccharide ✓
59 18.0 415 MS2 [415]: 370 (51.9), 227 (75.2), 225 (81.0), 187 (67.1), 179 (100), 161 (23.9), 131
(14.5)
MS3 [415→179]: 161 (100), 143 (14.2), 119 (15.3)
Saccharide ✓
60 18.9 609 MS2 [609]: 578 (10.7), 477 (43.7), 357 (11.1), 315 (100), 314 (82.8), 300 (29.7)
MS3 [609→315]: 301 (20.6), 300 (100), 299 (72.2), 287 (10.1), 271 (58.1), 255
(39.7), 243 (39.6)
Isorhamnetin-O-(pentosyl)hexoside ✓
61 19.0 463 MS2 [463]: 415 (99.4), 301 (100), 299 (37.1)
MS3 [463→301]: 151 (100)
Quercetin-O-hexoside ✓
62 19.0 549 MS2 [549]: 503 (100)
MS3 [549→503]: 417 (10.0), 371 (100), 353 (11.6), 191 (14.3), 173 (10.1), 161
(37.5), 149 (25.5), 143 (10.5)
MS4 [549→503→371]:161 (100)
Saccharide ✓
63 19.5 579 MS2 [579]: 429 (28.1), 339 (10.6), 285 (100), 284 (47.0), 257 (12.3), 255 (14.9)
MS3 [579→285]: 257 (94.1), 255 (100), 229 (83.2), 199 (28.9), 151 (54.8)
Kaempferol-O-pentosyl(hexoside) ✓
64 19.6 549 MS2 [549]: 504 (16.9), 503 (100)
MS3 [549→503]: 372 (28.9), 371 (100), 293 (17.3), 179 (15.4), 161 (22.3)
MS4 [549→503→371]: 179 (49.8), 161 (100), 131 (15.8), 119 (23.3), 113 (55.1)
Saccharide (formate adduct) ✓
65 20.4 609 MS2 [609]: 577 (10.7), 459 (35.1), 315 (100), 300 (25.9), 299 (21.1), 271 (14.8)
MS3 [609→315]:300 (100), 299 (72.2), 271 (45.8), 255 (45.9), 243 (11.5)
Isorhamnetin-O-pentosyl(hexoside) ✓
66 20.6 483 MS2 [483]: 434 (15.8), 413 (21.6), 410 (31.9), 331 (50.3), 313 (32.7), 211 (90.9),
177 (75.7), 169 (100), 151 (24.1)
MS3 [483→169]: 125 (100)
Digalloyl-O-glucoside ✓
67 21.3 839 MS2 [839]: 639 (14.4), 625 (100), 300 (11.5)
MS3 [839→625]: 505 (26.6), 463 (11.8), 445 (67.8), 301 (55.2), 300 (100), 299
(11.1), 271 (45.6), 179 (22.3)
MS4 [839→625→301]: 271 (100), 257 (11.4), 179 (66.0), 151 (26.6)
Quercetin-O-dihexoside derivative ✓
68 24.5 689 MS2 [689]: 635 (57.5), 519 (27.4), 465 (100), 313 (21.5)
MS3 [689→465]:313 (100), 295 (25.8), 169 (12.2), 125 (19.8)
MS4 [689→465→313]: 169 (100), 125 (21.5)
Trigalloylglucose derivative ✓
69 24.7 447 MS2 [447]: 285 (59.3), 284 (100), 255 (26.5)
MS3 [447→285]: 255 (100), 229 (21.4)
Kaempferol-O-hexoside ✓
70 25.8 515 MS2 [515]: 353 (100)
MS3 [515→353]: 191 (100), 179 (29.3), 161 (10.8), 135 (15.7)
3,5-O-Dicaffeoylquinic acid ✓
71 25.7 649 MS2 [649]: 469 (100)





72 25.8 477 MS2 [477]: 467 (20.9) 358 (26.0), 315 (100), 301 (14.9), 287 (42.3), 257 (10.9), 244
(14.0), 173 (42.9)
MS3 [477→315]: 300 (100), 285 (17.1), 271 (31.9)
Isorhamnetin-O-hexoside ✓
73 26.1 447 MS2 [447]:327 (10.2), 285 (100), 255 (16.2)
MS3 [447→285]: 255 (100), 229 (10.9), 201 (25.3)
Kaempferol-O-hexoside ✓ ✓
74 26.9 477 Isorhamnetin-O-hexoside ✓ ✓
(continued on next page)
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Table 1 (continued)
N° tR (min) [M-H]− (m/
z)
HPLC-DAD-ESI/MSn
m/z (% base peak)
Assigned identity Berries Leaves
MS2 [477]: 357 (10.3), 315 (100), 301 (10.5), 285 (27.4), 271 (14.1)
MS3 [477→315]: 301 (51.7), 300 (22.2), 299 (76.9), 286 (86.6), 285 (54.7), 271
(100), 257 (52.6), 243 (23.3)
75 27.0 845 MS2 [845]: 653 (82.1), 639 (100), 515 (18.0), 459 (12.8), 413 (11.1), 330 (11.0), 315
(23.0), 300 (10.4)
MS3 [845→639]: 607 (12.6), 491 (21.9), 477 (14.4), 459 (40.4), 417 (18.4), 393
(21.1), 315 (100), 300 (41.9)
MS4 [845→639→315]: 301 (24.4), 300 (100), 299 (49.6), 257 (13.2)
Isorhamnetin-O-(sinapoyl)dihexoside ✓
76 27.1 447 MS2 [447]:285 (100), 284 (97.4), 255 (29.8)
MS3 [447→285]: 255 (100), 229 (10.3)
Kaempferol-O-hexoside ✓
77 27.9 579 MS2 [579]: 533 (14.3), 315 (100), 299 (13.4), 271 (14.8)
MS3 [579→315]: 300 (100), 299 (15.1), 271 (34.9), 151 (15.6)
Isorhamnetin-O-dipentoside ✓
78 28.0 429 MS2 [429]: 249 (100), 205 (89.2), 179 (13.7), 161 (63.7), 135 (17.2) Caffeic acid derivative ✓
79 28.7 815 MS2 [815]: 653 (63.0), 639 (100), 485 (11.4), 329 (11.0), 315 (18.9)
MS3 [815→639]: 607 (18.8), 580 (23.4), 491 (20.7), 459 (46.1), 433 (18.3), 357
(53.8), 315 (100), 301 (25.7), 300 (46.2), 299 (16.1), 271 (26.5)




80 29.3 755 MS2 [755]: 609 (100)
MS3 [755→609]: 429 (57.5), 285 (100), 284 (33.9), 255 (11.2)
MS4 [755→609→285]: 257 (25.0), 255 (100)
Kaempferol-O-(coumaroyl)dihexoside ✓
81 30.5 711 MS2 [711]:665 (10.5), 505 (10.2), 503 (100)
MS3 [711→503]: 485 (55.0), 453 (100), 421 (78.3), 417 (61.3), 410 (53.2), 409
(92.0), 380 (50.4)




82 31.1 727 MS2 [727]: 681 (100), 619 (27.7)
MS3 [727→681]:619 (100)
MS4 [727→681→619]:457 (100), 425 (25.3)
Unknown ✓
83 31.9 711 MS2 [711]: 665 (100)
MS3 [711→665]:621 (100), 589 (27.5), 459 (13.4)
MS3 [711→665→621]: 590 (100), 459 (26.7), 428 (54.5); 459 (100)
Unknown ✓
84 32.7 805 MS2 [805]: 639 (100), 459 (30.1), 315 (87.2), 300 (26.0), 271 (11.4)
MS3 [805→315]: 300 (100), 299 (33.8), 287 (17.9), 151 (23.0)
Isorhamnetin-O-dihexoside derivative ✓
85 33.0 591 MS2 [591]:567 (52.0), 544 (30.7), 367 (24.9), 265 (28.4, 223 (100), 205 (28.1), 190
(14.9), 164 (12.8)
MS3 [591→223]:208 (88.8), 179 (17.0), 164 (100)
Disinapoyl-O-hexoside ✓
86 34.9 581 MS2 [581]:559 (100), 558 (31.9)
MS3 [581→559]: 535 (21.4), 477 (10.4), 455 (20.2), 454 (100)
MS4 [581→559→454]: 373 (100)
Unknown ✓
87 35.8 593 MS2 [593]: 447 (12.1), 284 (100)
MS3 [593→285]: 267 (19.1), 257 (56.0), 255 (32.7), 229 (31.2), 213 (28.1), 163
(20.6), 151 (100)
Kaempferol-O-(coumaroyl)hexoside ✓ ✓
88 36.2 581 MS2 [581]: 461 (100), 341 (29.4)
MS3 [581→461]: 341 (100)
MS4 [581→461→341]: 299 (100), 284 (37.4), 271 (26.0), 151 (44.6)
Diosmetin-8-C-hexoside-C-hexoside ✓
89 36.6 593 MS2 [593]: 447 (10.5), 286 (12.5), 285 (100)
MS3 [593→285]: 257 (35.5), 241 (24.1), 229 (18.9), 213 (18.3), 151 (1000), 123
(11.9)
Kaempferol-O-(coumaroyl)hexoside ✓ ✓
90 36.8 623 MS2 [623]: 461 (78.3), 323 (56.9), 315 (11.0), 301 (15.8), 299 (100), 285 (98.4), 256
(21.4)
MS3 [623→299]: 284 (100), 271 (40.4), 256 (47.3)
MS4 [623→299→284]: 256 (100), 151 (43.1)
Diosmetin-O-dihexoside ✓
91 37.4 581 MS2 [581]:461 (100), 341 (28.5)
MS3 [581→461]: 341 (100)
MS4 [581→461→341]: 299 (100), 284 (17.6), 151 (68.8)
Diosmetin-8-C-hexoside-C-hexoside ✓
92 37.5 613 MS2 [613]:492 (100), 476 (39.9), 466 (40.0), 462 (20.8), 342 (10.3)
MS3 [613→492]: 451 (16.5), 449 (100), 373 (22.8), 343 (47.3), 342 (62.6), 299
(14.3), 160 (11.7)
MS4 [613→492→449]: 303 (23.4), 299 (100), 149 (55.5), 145 (17.2)
Unknown ✓
93 38.3 613 MS2 [613]: 492 (100), 476 (39.9), 466 (40.0), 462 (20.8), 342 (10.3)
MS3 [613→492]: 451 (16.5), 449 (100), 373 (22.8), 357 (12.3), 343 (47.3), 342
(62.6), 299 (14.3), 288 (14.6), 145 (10.3)
MS4 [613→492→372]: 357 (100), 175 (51.1)
MS4 [613→492→449]: 376 (23.8), 329 (25.8), 314 (49.6), 303 (23.0), 299 (21.5),
289 (14.1), 157 (100), 149 (14.1), 135 (16.8)
MS4 [612→492→449]: 275 (100), 233 (36.6), 174 (88.5), 145 (41.7), 134 (20.2)
Unknown ✓
94 39.0 533 MS2[533]: 487 (100)
MS3 [533→487]: 451 (24.4), 427 (53.3), 355 (46.0), 221 (51.3), 191 (45.1), 161
(41.7), 149 (100), 143 (52.8)
MS4 [533→487→149]:131 (12.4), 85 (100)
Saccharide ✓
HHDP: Hexahydroxydiphenoyl.
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3.3. In vitro inhibition of digestive enzymes
Inhibition of dietary sugar and fat intestinal metabolism seems to be
an effective way to prevent T2DM and obesity (Grussu, Stewart, &
McDougall, 2011; McDougall, Kulkarni, & Stewart, 2009; Podsędek
et al., 2014; You et al., 2011). Currently, acarbose, miglitol, voglibose
and orlistat are approved oral drugs for this purpose (Grussu et al.,
2011; McDougall & Stewart, 2005). However, these agents can cause
side/adverse effects such as abdominal pain, flatulence, diarrhea and
liver toxicity (Nazir et al., 2018). Berries have been studied for their
ability to modulate sugars and fats digestion/breakdown through in-
hibition of key digestive enzymes, leading to delayed glycaemic re-
sponse and reduced calorie intake (Edirisinghe & Burton-Freeman,
2016; Ho, Nguyen, et al., 2017; McDougall et al., 2008, 2009;
Worsztynowicz et al., 2014).
In this work, leaves were more potent than berries towards inhibi-
tion of α-glucosidase (Table 3). No statistical differences were found
between leaves extracts of both analysed species (p < .05). Acarbose
and 1-DNJ (1-deoxynojirimycin or moranoline), a natural α-glucosidase
inhibitor isolated from Morus spp. leaves (Borges de Melo, da Silveira
Gomes, & Carvalho, 2006), were the most active agents (Table 3).
Acarbose was the most active agent in the α-amylase inhibitory
assay (Table 3). A different potency was observed in this case: E. um-
bellata (leaves) > berries (E. umbellata > S. lanceolata) > S. lanceo-
lata (leaves).
In the case of lipase, the anti-obesity drug orlistat exhibited the most
potent inhibitory activity (Table 3). In this assay, leaves (E. umbel-
lata > S. lanceolata) were also more active than berries (S. lanceo-
lata > E. umbellata).
In the present work, the inhibitory activity of carbohydrate-
Table 2
Quantification (mg g−1 dry extract, DE) of main phenolic compounds of E. umbellata methanolic extracts (berries and leaves) before (Undigested) and after the
complete in vitro gastrointestinal digestion (Digested). Data represent the mean ± standard deviation (n=3).
N° [M-H]− Assigned identification Berries Leaves
Undigested Digested Undigested Digested
Hydroxycinnamic acids
28 565 Sinapic acid-O-(pentosyl)hexoside 0.10 ± 0.01a 1.42 ± 0.04b N.D.
35 385 Sinapic acid-O-hexoside 0.18 ± 0.02b 0.08 ± 0.01a
41 503 Sinapic acid derivative 0.31 ± 0.01b 0.11 ± 0.01a
78 429 Caffeic acid derivative
85 591 Disinapoyl-O-hexoside 0.21 ± 0.02 N.D.
Total 0.10 ± 0.01a 2.13 ± 0.07c 0.20 ± 0.01b
Flavonols
14 757 Quercetin-O-(pentosyl)dihexoside 0.67 ± 0.03b 0.22 ± 0.08a
26 755 Kaempferol-O-dihexoside-O-rhamnoside 0.06 ± 0.01
33 759 Isorhamnetin-O-glucuronide derivative 0.17 ± 0.01
37 449 Dihydrokaempferol-O-hexoside 0.21 ± 0.01
38 755 Isorhamnetin-O-(pentosyl)hexoside-O-rhamnoside 0.17 ± 0.01
43 625 Quercetin-O-dihexoside 0.59 ± 0.02b 0.20 ± 0.01a
48 595 Quercetin-O-(pentosyl)hexoside 0.19 ± 0.01
49 433 Quercetin-O-pentoside 0.47 ± 0.01b 0.19 ± 0.05a
51 595 Quercetin-O-pentosyl(hexoside) 5.05 ± 0.25b 2.37 ± 0.05a
54 639 Isorhamnetin-O-dihexoside 0.39 ± 0.01b 0.12 ± 0.01a
60 609 Isorhamnetin-O-(pentosyl)hexoside 0.14 ± 0.01
61 463 Quercetin-O-hexoside 0.13 ± 0.01
65 609 Isorhamnetin-O-pentosyl(hexoside) 3.94 ± 0.14b 1.27 ± 0.03a
73 447 Kaempferol-O-hexoside 0.34 ± 0.01c 0.13 ± 0.02a 0.51 ± 0.02d 0.22 ± 0.01b
74 477 Isorhamnetin-O-hexoside 1.71 ± 0.05b 0.73 ± 0.03a
79 815 Isorhamnetin-O-dihexoside-O-glucuronide
80 755 Kaempferol-O-(coumaroyl)dihexoside 0.07 ± 0.01
84 805 Isorhamnetin-O-dihexoside derivative 0.94 ± 0.01b 0.22 ± 0.01a
87 593 Kaempferol-O-(coumaroyl)hexoside 2.07 ± 0.13c 0.98 ± 0.03a 2.02 ± 0.05c 1.17 ± 0.31b
89 593 Kaempferol-O-(coumaroyl)hexoside 0.37 ± 0.05c 0.14 ± 0.01a 0.62 ± 0.02d 0.21 ± 0.02b
Total 4.38 ± 0.12b 1.43 ± 0.08a 16.45 ± 0.55d 6.74 ± 0.43c
Flavones
88 583 Diosmetin-8-C-hexoside-C-hexoside 0.09 ± 0.01
90 623 Diosmetin-O-dihexoside 0.1 ± 0.01b 0.06 ± 0.01a
91 583 Diosmetin-8-C-hexoside-C-hexoside 0.24 ± 0.01b 0.11 ± 0.01a
Total 0.43 ± 0.03b 0.18 ± 0.02a
Flavan-3-ols
16 305 Gallo(epi)catechin 0.15 ± 0.01a 0.85 ± 0.03b
Total 0.15 ± 0.01a 0.85 ± 0.03b
Ellagic acid derivatives/ Ellagitannins
13 783 bis-HHDP-O-glucose 1.21 ± 0.03
15 783 bis-HHDP-O-glucose 3.28 ± 0.09b 1.54 ± 0.13a
17 783 bis-HHDP-O-glucose 10.77 ± 0.13b 4.03 ± 0.32a
21 633 Galloyl-HHDP-O-hexoside 0.16 ± 0.01 6.25 ± 0.04b 2.39 ± 0.09a
24 935 Galloyl-bis-HHDP-O-glucose 0.35 ± 0.01
40 463 Ellagic acid-O-hexoside 0.28 ± 0.01 N.D.
42 475 Ellagic acid-O-(acetyl)pentoside 1.15 ± 0.01b 0.61 ± 0.03a
Total 0.50 ± 0.03a 22.93 ± 0.30c 8.58 ± 0.33b
TIPC 5.56 ± 0.19b 1.61 ± 0.09a 42.35 ± 0.95d 15.52 ± 0.84c
N.D.: not determined. HHDP: Hexahydroxydiphenoyl; TIPC: Total individual phenolic content. Bold values represent the sum of each type of components. Means not
sharing the same letter are significantly different at p < .05 probality level.
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hydrolysing enzymes was not correlated with the TIPC of the analysed
samples. Poor correlations (r≤−0.332) were also reported on a pre-
vious work (Podsędek et al., 2014), suggesting that the type of phe-
nolics is more pertinent for the inhibitory effects towards digestive
enzymes than the total phenolic amounts. The main enzymes involved
in the final digestive step of carbohydrates are α-amylase and α-glu-
cosidase (Grussu et al., 2011; Ho, Nguyen, et al., 2017; Podsędek et al.,
2014). α-Glucosidase is susceptible to a large variety of phenolic
compounds (anthocyanins, caffeoylquinic acids (CQAs), flavonols)
(McDougall et al., 2008; McDougall & Stewart, 2005). Hence, the very
distinct phenolic compositions of the analysed berry species (Fig. 1)
could have dictated this outcome. Differences in composition and
contents of phenolic compounds are known to affect their inhibitory
activity towards enzymes. The large diversity in the structures between
different groups of phenolic compounds, as well as within the same
group, determines their ability to bind to digestive enzymes (Ho, Kase,
et al., 2017; Podsędek et al., 2014). Additionally, phenolic compounds
present in the extracts could act synergistically and/or antagonistically
towards enzymes and influence the inhibitory activities (Grussu et al.,
2011; Podsędek et al., 2014; Worsztynowicz et al., 2014). Previously
(Ho, Kase, et al., 2017; Ho, Nguyen, et al., 2017), S. nigra (elderberry)
berry extracts showed potent α-glucosidase activities. Anthocyanins
(cyanidin-3-O-sambubioside, cyanidin-3-O-glucoside, and cyanidin)
and proanthocyanidins (B2, B5 and C1), isolated from berries, were
reported as the main inhibitory agents (Ho, Kase, et al., 2017). An-
thocyanins are important α-glucosidase inhibitors (McDougall et al.,
2008; McDougall & Stewart, 2005). However, this study shows the lack
of anthocyanins in E. umbellata (Table 3) and still a remarkable bioac-
tivity. M. faya berries (with comparable anthocyanins content to S.
lanceolata) displayed higher potencies (Spínola, Llorent-Martínez, &
Castilho, 2019). Berries were composed by cyanidin-3-O-glucoside,
while S. lanceolata by cyanidin-O-sambubioside (a diglycoside). It
seems that the nature of sugar moieties attached to the cyanidin agly-
cone modulate the bioactivity of anthocyanins. For example, cyanidin-
3,5-diglycoside had no inhibitory activity against α-glucosidase, while
cyanidin and its mono-glycosides were effective inhibitors
(Akkarachiyasit, Charoenlertkul, Yibchok-Anun, & Adisakwattana,
2010). Ellagitannins have a low impact on the activity of α-glucosidase
activity, while CQAs are strong inhibitors (McDougall & Stewart, 2005;
Meng, Cao, Feng, Peng, & Hu, 2013). 3-O-CQA was dominant in S.
lanceolata leaves (41% of TIPC) (Pinto et al., 2017) and could justify the
identical efficacy to E. umbellata leaves (Table 3), which are composed
mainly by ellagitannins (56.83%) (Table 2).
α-Amylase activity is primarily affected by condensed (ellagi-
tannins) and hydrolysable tannins (proanthocyanidins) (McDougall &
Stewart, 2005). In fact, E. umbellata (rich in ellagitannins) displayed the
highest inhibitory activity (Table 3). Recently (Nazir et al., 2018), rutin,
quercetin, and epigallocatechin gallate were the main contributors of E.
umbellata berries against α-amylase. Anthocyanins from S. nigra showed
strong inhibition of α-amylase (Ho, Kase, et al., 2017). This could
partially justify the higher effect of S. lanceolata berries by comparison
with respective leaves (Table 3). However, some authors (Grussu et al.,
2011; Worsztynowicz et al., 2014) state that anthocyanins are not
crucial for α-amylase inhibition but their presence can potentiate the
effectiveness of other phenolic compounds present in berries. Although
no correlation was observed in the present study, these data could be
indicative of the impact of these phenolic classes against α-amylase
activity.
Pancreatic lipase is responsible for the hydrolysis of 50–70% of
dietary fats into monoacylglycerols and free fatty acids the intestinal
lumen (McDougall et al., 2009). Inhibition of this enzyme is efficient in
weight management and obesity control in diabetic patients (Podsędek
et al., 2014). In the lipase assay, a strong correlation with TIPC was
obtained (r=−0.962), flavonols (r=−0.852) and ellagitannins
(r=−0.806) being key inhibitors of lipase. The catabolic activity of
lipase is more specific and ellagitannins are also reported to be the main
inhibitors (McDougall et al., 2008, 2009). Anthocyanins
(Worsztynowicz et al., 2014; You et al., 2011) and CQAs (Meng et al.,
2013) are also reported inhibitors, which could justify the higher po-
tencies of S. lanceolata samples compared to E. umbellata berries.
3.4. In vitro inhibition of human aldose reductase (HAR)
Most studies using phenolic compounds focus only at maintaining
the glycaemic control, through inhibition of digestive enzymes. So,
many of these hypoglycaemic agents have not been investigated for
their beneficial effects on secondary complications of T2DM
Fig. 1. Content of phenolic compounds (mg g−1 DE) of studied species before
(Undigested) and after complete in vitro gastrointestinal digestion (Digested).
TIPC: total individual phenolic content. UD: Undigested. D: Digested.
Table 3
In vitro inhibitory activities of studied species extracts towards digestive en-
zymes linked to sugars and fats metabolism. Results are expressed as the IC50
value (mgmL−1). Data represent the mean ± standard deviation (n=3).
α-Glucosidase α-Amylase Lipase
Berries
E. umbellata 6.02 ± 0.23d 4.01 ± 0.20c 9.68 ± 0.51e
S. lanceolata 7.55 ± 0.27e 6.01 ± 0.54d 7.75 ± 0.48d
Leaves
E. umbellata 4.76 ± 0.09c 2.18 ± 0.13b 5.03 ± 0.22b
S. lanceolata 4.97 ± 0.25c 7.71 ± 0.32e 6.64 ± 0.25c
Reference compounds
Acarbose 0.12 ± 0.01b 0.02 ± 0.01a –
1-DNJ 0.01 ± 0.01a – –
Orlistat – 0.47 ± 0.02a
1-DNJ: 1-deoxynojirimycin; Means in the same column not sharing the same
letter are significantly different at p < .05 probability level.
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(retinopathy, neuropathy, nephropathy, etc.), triggered by chronic hy-
perglycaemia. The overactivity of the polyol pathway is associated with
the pathogenesis of diabetic complications (Grewal et al., 2016;
Khangholi, Majid, Berwary, Ahmad, & Aziz, 2016). In hyperglycaemia
conditions, aldose reductase catalyses the reduction of excessive glu-
cose to sorbitol, which is the first reaction of the polyol pathway. Then,
sorbitol dehydrogenase reduces sorbitol to fructose, which intensifies to
the formation of advanced glycation end-products (AGEs) (Grewal
et al., 2016; Suryanarayana, Kumar, Saraswat, Petrash, & Reddy, 2004).
Hence, inhibition of the aldose reductase activity is another therapeutic
target for the mitigation of T2DM signs (Grewal et al., 2016; Khangholi
et al., 2016; Suryanarayana et al., 2004).
The analysed extracts interfered with the catabolic activity of HAR,
although in lower extent than the quercetin standard (positive control)
(p < .05) (Table 4). E. umbellata extracts were the most active samples
(leaves> berries). A poor correlation (r=−0.241) was found between
TIPC and the reported bioactivities. Ellagitannins were the main active
agents (r=−0.838) for this assay and are documented as strong aldose
reductase inhibitors (Suryanarayana et al., 2004).
After simulated gastrointestinal digestion, extracts presented a
much lower inhibitory activity towards HAR (p < .05) (Table 4). An
increase of the IC50 values (60–77%) was observed. This should be
linked with the reduced amounts of phenolic compounds present in the
digested extracts (Table 2). Correlations of HAR activity with TIPC
improved after the digestion process (r=−0.838), being flavonols
(r=−0.968) and ellagitannins (r=−0.939) the compounds that
contributed the most. Although in lower potency, phenolic compounds
present in digested extracts still displayed inhibitory effects against
HAR, meaning that they could potentially exert their beneficial effects
on target tissues after digestion.
3.5. In vitro inhibition of advanced glycation end-products (AGEs)
generation
The elevated blood glucose levels can also cause glycation of pro-
teins (albumin collagen, elastin), and consequently, accumulation of
AGEs in human tissues (Bains & Gugliucci, 2017; Khangholi et al., 2016;
Yeh et al., 2017). Also, the excessive production of fructose, though the
overactivated polyol pathway, intensifies the generation of AGEs
(Wang, Yagiz, Buran, Nunes, & Gu, 2011). These adducts are originated
via binding of carbonyl groups of reducing sugars (glucose, fructose,
ribose) to free amino groups of proteins (Maillard reaction). The first
glycation product is the highly reversible Schiff base intermediates
(glucosamines), which are further converted to more stable Amadori
products. These molecules undergo a series of reactions resulting in
carbonyl compounds (glyoxal, methylglyoxal, 3-deoxyglucosone)
(Beaulieu et al., 2010; Khangholi et al., 2016). AGEs lead to structural
and functional changes in cellular and tissues components (proteins,
lipids, DNA), being implicated in the pathogenesis of angiopathy,
neuropathy, nephropathy, etc. in diabetic patients (Yeh et al., 2017).
Therefore, inhibition of protein glycation may be an alternative ther-
apeutic approach for delaying and averting some diabetic complica-
tions (Beaulieu et al., 2010; Harris et al., 2014; Wang et al., 2011).
The analysed extracts were found to prevent protein glycation, al-
though with different potencies between sugar models (Table 4). In the
case of ribose as glycation agent, samples were more active than ami-
noguanidine (AMG), a synthetic AGEs inhibitor. Leaves displayed
higher inhibitory activities than berries; E. umbellata showing the
strongest results (Table 4). When fructose was used, only E. umbellata
leaves were more active than AMG (p < .05). Leaves of S. lanceolata
showed a comparable result to that of AMG, while berries were less
potent (E. umbellata > S. lanceolata) (Table 4). Quercetin standard
displayed the best inhibitory results (in both models) (Table 4). A si-
milar trend was documented before using pure quercetin as positive
control (Beaulieu et al., 2010; Harris et al., 2014). Samples were more
active in the fructose model (lower IC50 values) than in ribose. The
reactivity of individual sugars depends largely on the proportion that
exists in the open-chain form (Harding & Ganea, 2006). D-ribose is the
most reactive reducing sugar in the glycation of proteins due to its
unstable aldofuranose ring (two OH in axial position) (Bains &
Gugliucci, 2017; Wei et al., 2012). Hence, the abundance of ribose in
open chain form is higher than fructose, the former being more vul-
nerable to reactions with amino groups of proteins (Wei et al., 2012).
Inhibition of BSA glycation was poorly correlated with TIPC
(r≤−0.546). From a parallel works (Spínola et al., 2018; Spínola,
Llorent-Martínez, & Castilho, 2019; Spínola, Pinto, et al., 2019), species
with higher TIPC (M. faya, R. grandifolius and Vaccinium spp.) were
more effective towards inhibition of AGEs formation than analysed
extracts. In the present study, flavonols played a determinant role in the
prevention of AGEs generation (r≥−0.958); they are reported to be
effective anti-glycative compounds (Yeh et al., 2017).
Upon digestion, the analysed extracts were still able to prevent the
in vitro glycation of BSA (Table 5), albeit in lower potency (p < .05).
The increase of IC50 values (40–62%) suggested that digested extracts
showed lower inhibitory activity against formation of AGEs. Again, the
reduced levels of phenolic compounds in the digested extracts (Table 2)
is associated with this outcome. After digestion, correlation was im-
proved with TIPC (r≥−0.845); flavonols remained the main con-
tributors for these bioactivities (r≥−0.944). Bains and Gugliucci
(2017) showed that formation of fructose-AGEs in the enteral lumen
occurs after consumption of fructose-rich foodstuffs. Hence, the anti-
glycative effects of phenolic compounds can prevent the generation of
AGEs, which, after being absorbed may contribute to inflammatory
diseases. This data together with inhibition of HAR (section 3.4), in-
dicates another potential therapeutic mechanism of analysed species
against long-term diabetic complications, besides lowering
Table 4
In vitro inhibitory activities of studied species towards human aldose reductase and glycation of BSA before (Undigested) and after the complete in vitro gastro-
intestinal digestion (Digested). Results are expressed as the IC50 value (mgmL−1). Data represent the mean ± standard deviation (n=3).
Aldose reductase BSA glycation - ribose BSA glycation - fructose
Undigested Digested Undigested Digested Undigested Digested
Berries
E. umbellata 2.19 ± 0.10c 9.34 ± 0.50g 5.35 ± 0.21d 9.34 ± 0.21g 2.75 ± 0.15d 6.31 ± 0.25g
S. lanceolata 4.46 ± 0.17f 12.41 ± 0.5 h 6.04 ± 0.30e 11.21 ± 0.25h 4.10 ± 0.15f 8.15 ± 0.31h
Leaves
E. umbellata 0.86 ± 0.02b 2.51 ± 0.10d 2.38 ± 0.10b 5.69 ± 0.22d 1.22 ± 0.05b 3.25 ± 0.14e
S. lanceolata 3.61 ± 0.14e 9.07 ± 0.38g 4.47 ± 0.16c 7.41 ± 0.33f 2.30 ± 0.08c 4.48 ± 0.10f
Reference compounds
AMG – – 9.56 ± 0.36g – 2.29 ± 0.13c –
Quercetin 0.10 ± 0.01a – 0.11 ± 0.01a – 0.24 ± 0.02a –
AMG: Aminoguanidine; N.I.: no inhibition. Means in the same assay not sharing the same letter are significantly different at p < .05 probability level.
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hyperglycaemia through modulation of carbohydrate-hydrolysing en-
zymes activity (section 3.3).
3.6. In vitro antioxidant assays
Hyperglycaemia intensifies the production of reactive oxygen spe-
cies (ROS) that have been implicated as a contributing factor in the
development and progression of T2DM (Grewal et al., 2016; Ho, Kase,
et al., 2017; Ho, Nguyen, et al., 2017). Berries are reported to possess
high antioxidant activities due to its considerable amounts of phenolic
compounds (Bermúdez-Soto et al., 2007; Edirisinghe & Burton-
Freeman, 2016). Antioxidants, such as phenolic compounds, poses hy-
poglycaemic effects through at least two means, by inhibiting oxidative
formation of AGEs and by scavenging ROS (Beaulieu et al., 2010; Yeh
et al., 2017). Hence, dietary intake of berries seems beneficial to pre-
vent oxidative damage and diabetic complications (Edirisinghe &
Burton-Freeman, 2016; Podsędek et al., 2014).
The antioxidant activity of E. umbellata extracts was assessed by four
in vitro assays, using synthetic (ABTS+•, DPPH•) and biological radicals
(NO•, O2•-).
Leaves showed the best results among all assays (Table 5). The
scavenging activities of E. umbellata extracts (berries and leaves) have
been reported (Ishaq et al., 2015; Khattak, 2012; Kim et al., 2016; Nazir
et al., 2018; Ozen et al., 2017). However, the results are expressed as
the IC50 values, which make it difficult to establish a comparison with
the present data. Nevertheless, leaves showed stronger antioxidant ac-
tivities than berries (Kim et al., 2016), which agrees with the present
results. By comparison, S. lanceolata berries (analysed under the same
conditions) (Pinto et al., 2017) displayed higher overall activities than
E. umbellata counterparts. It seems that the present antioxidant activ-
ities are related to the total phenolic contents of analysed extracts, since
samples with the highest TIPC showed, in general, the greatest anti-
oxidant activities (r≥0.805). Flavonols (r≥0.913) and ellagitannins
(r≥0.826) were the main contributors for the obtained results. In fact,
R. grandifolius,M. faya and Vaccinium spp. with higher flavonols and/or
ellagitannins contents, displayed superior antioxidant activities than
analysed species (Spínola et al., 2018; Spínola, Llorent-Martínez, &
Castilho, 2019; Spínola, Pinto, et al., 2019).
Most studies that evaluate the antioxidant activity of berries do not
consider the intensive metabolism and chemical alterations occurring
during digestion, with a consequential impact on their bioactivity. This
work demonstrates that the physiochemical changes occurring in the
gastrointestinal tract should be considered when evaluating the po-
tential antioxidant activity (Tagliazucchi et al., 2010). The lower anti-
oxidant activities noted after digestion (Table 5) are probably the result
of the lower phenolic content in the digested samples (Table 3). Similar
results were also reported in other studies (Correa-Betanzo et al., 2014;
Huang et al., 2014; Olejnik et al., 2016; Zhang et al., 2016), concluding
that the digestion contributed to the loss of antioxidant capacity of
berry-producing plants. Correlations between the antioxidant assays
and TIPC were enhanced after the in vitro digestion (r≥−0.875). El-
lagitannins (r≥0.920) and flavonols (r≥0.902) remained the most
active compounds.
Since phenolic compounds are highly sensitive to the mild-alkaline
conditions in the intestinal step, during gastrointestinal digestion, they
undergo structural modifications and/or degradation and their bioac-
tivities are affected (Bermúdez-Soto et al., 2007; Correa-Betanzo et al.,
2014). The high pH values in the intestinal phase may induce depro-
tonation of the hydroxyl groups of phenolic compounds, making them
unavailable to react with free radicals (Tagliazucchi et al., 2010). In
addition, phenolic compounds may also interact with other constituents
of the sample (proteins, lipids, fibers, polysaccharides), making them
unavailable to react with free radicals (Bermúdez-Soto et al., 2007;
Correa-Betanzo et al., 2014). Nevertheless, despite extensive degrada-
tion following digestion, analysed extracts still showed the capacity to
scavenge free radicals (although in a minor extent). Whether or not the
phenolic compounds are absorbed in the gut, the ones that maintain
their antioxidant activity, after digestion, might carried out their po-
tential beneficial effects in the gastrointestinal tract by scavenging ROS
(Grussu et al., 2011; Liang et al., 2012; Tagliazucchi et al., 2010).
4. Conclusions
In this study, the enzyme-inhibitory properties and the antioxidant
activities of two berry-producing plants – E. umbellata and S. lanceolata
– have been studied and discussed in terms of their phenolic composi-
tion. It was observed that the analysed extracts presented effective in-
hibitory activities against key enzymes linked to T2DM and obesity. The
analysed species were also able to prevent protein glycation and sca-
venge free radicals, highlighting their use as natural sources of biolo-
gically active compounds (in particular ellagitannins and flavonols).
The gastrointestinal digestion simulation affected the phenolic content
of E. umbellata and S. lanceolata. These changes were correlated with
the decrease of in vitro anti-diabetic and antioxidant activities.
However, despite these modifications, this study highlights the use of
both species as dietary hypoglycaemic, anti-glycation and antioxidant
agents (more pronounced for E. umbellata). It also demonstrates that
bioactive compounds in leaves are more abundant that in berries and
that anthocyanins, albeit important, are not the most relevant compo-
nents when other substances, such as flavonoids and/or ellagic acid
derivatives are available.
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Table 5
In vitro antioxidant activities of E. umbellata methanolic extracts (berries and
leaves) before (Undigested) and after the complete in vitro gastrointestinal di-
gestion (Digested). Results are expressed as mmol Trolox equivalents per g of
dry extract (mmol TE g−1 DE). Data represent the mean ± standard deviation
(n=3).
Berries Leaves
Undigested Digested Undigested Digested
ABTS+• 0.68 ± 0.02b 0.17 ± 0.01a 4.71 ± 0.18d 1.90 ± 0.04c
DPPH• 0.13 ± 0.01a 0.14 ± 0.01b 0.84 ± 0.02d 0.33 ± 0.01c
NO• 0.08 ± 0.01b 0.02 ± 0.01a 0.39 ± 0.01d 0.14 ± 0.01c
O2•- 0.03 ± 0.01b 0.01 ± 0.01a 0.22 ± 0.01d 0.09 ± 0.01c
Means in the same line not sharing the same letter are significantly different at
p < .05 probability level.
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